PAS
CRL icon

Park Avenue Securities’s Charles River Laboratories CRL Stock Holding History

Park Avenue Securities’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$388K Sell
1,711
-124
-7% -$22.1K ﹤0.01% 1407
2026
Q1 		$317K Sell
1,835
-222
-11% -$41.2K ﹤0.01% 1290
2025
Q4 		$410K Buy
2,057
+118
+6% +$21.4K ﹤0.01% 1183
2025
Q3 		$303K Sell
1,939
-60
-3% -$9.53K ﹤0.01% 1416
2025
Q2 		$303K Buy
+1,999
New +$267K ﹤0.01% 1279
2025
Q1 		– Sell
-2,785
Closed -$514K – 1238
2024
Q4 		$514K Sell
2,785
-559
-17% -$108K 0.01% 1060
2024
Q3 		$659K Sell
3,344
-557
-14% -$116K 0.01% 864
2024
Q2 		$806K Buy
3,901
+86
+2% +$19.5K 0.01% 765
2024
Q1 		$1.03M Buy
3,815
+203
+6% +$48.5K 0.01% 648
2023
Q4 		$854K Sell
3,612
-446
-11% -$87.7K 0.01% 688
2023
Q3 		$795K Buy
+4,058
New +$833K 0.01% 656
2023
Q1 		– Sell
-3,825
Closed -$833K – 794
2022
Q4 		$833K Buy
3,825
+277
+8% +$60.5K 0.01% 604
2022
Q3 		$698K Sell
3,548
-4,775
-57% -$1.03M 0.01% 602
2022
Q2 		$1.78M Sell
8,323
-231
-3% -$56.4K 0.03% 294
2022
Q1 		$2.43M Buy
8,554
+1,916
+29% +$591K 0.04% 237
2021
Q4 		$2.5M Buy
6,638
+394
+6% +$153K 0.04% 241
2021
Q3 		$2.58M Buy
6,244
+27
+0.4% +$11.2K 0.05% 197
2021
Q2 		$2.3M Buy
6,217
+442
+8% +$148K 0.05% 203
2021
Q1 		$1.67M Buy
5,775
+556
+11% +$155K 0.04% 231
2020
Q4 		$1.3M Buy
5,219
+141
+3% +$33.6K 0.04% 234
2020
Q3 		$1.15M Buy
5,078
+504
+11% +$105K 0.04% 214
2020
Q2 		$797K Buy
+4,574
New +$730K 0.03% 235
2020
Q1 		– Sell
-4,936
Closed -$754K – 349
2019
Q4 		$754K Buy
4,936
+283
+6% +$39.2K 0.03% 223
2019
Q3 		$616K Buy
+4,653
New +$624K 0.03% 215

Other funds holding CRL

BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
LKIM
Lawson Kroeker Investment Management Omaha, Nebraska $361M AUM 22.26% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
JIC
Johnson Investment Counsel Cincinnati, Ohio $13.7B AUM 21.52% 1-Year Est. Return

Park Avenue Securities's CRL Position: Q2 2026 in Review

Park Avenue Securities reduced its Charles River Laboratories (CRL) stake by 6.8% in Q2 2026, selling an estimated $22.1K and leaving 1,711 shares worth $388K. The position accounts for ﹤0.01% of the portfolio, ranked #1407.

Park Avenue Securities first reported a position in CRL in Q3 2019 and has held it in 24 quarters since. The position peaked at $2.58M in Q3 2021. 137 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Park Avenue Securities held 1,711 shares of Charles River Laboratories worth $388K as of Q2 2026.
  • Park Avenue Securities sold 124 Charles River Laboratories shares in Q2 2026, an estimated $22.1K.
  • Charles River Laboratories made up ﹤0.01% of Park Avenue Securities's portfolio in Q2 2026, its #1407 holding.
  • Park Avenue Securities first reported a position in Charles River Laboratories in Q3 2019 and has held it in 24 quarters since.
  • Park Avenue Securities's Charles River Laboratories position peaked at $2.58M in Q3 2021.
  • 137 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.